[Form 4] Gabelli Healthcare & WellnessRx Trust Insider Trading Activity

Rhea-AI Filing Summary

Saba Capital Management, L.P. reported two open-market purchases of Gabelli Healthcare & WellnessRx Trust (GRX) common stock on 09/11/2025 and 09/12/2025 at $9.43 per share. The first purchase was 6,147 shares, bringing indirect beneficial ownership to 2,043,303 shares; the second added 7,732 shares, increasing indirect ownership to 2,051,035. The filing lists the reporting person as a Director and a 10% owner and is signed by Zachary Gindes and Boaz Weinstein on 09/15/2025.

Positive

• Timely disclosure of insider purchases with dates, amounts, and price provided
• Incremental increase to indirect beneficial ownership to 2,051,035 shares
• Open-market purchases at a single disclosed price of $9.43 indicate routine accumulation

Negative

• None.

Insights

Financial Analyst

TL;DR: Insider investor Saba added ~13.9k GRX shares over two days at $9.43, modestly increasing an >2M share indirect stake.

The purchases are small relative to the existing reported indirect stake of 2.05 million shares, indicating incremental accumulation rather than a material position change. The transactions were executed at a single reported price point of $9.43 and occurred on consecutive days, which is consistent with routine open-market buying. For investors, this filing documents insider confidence but does not alone imply a material shift in ownership or control.

Corporate Governance Expert

TL;DR: A reporting entity identified as a director and 10% owner increased indirect holdings via small open-market purchases.

From a governance perspective, the filing is routine: purchases are disclosed promptly and the form is signed by authorized representatives. The indirect nature of the holdings should prompt review of any disclosure about affiliated entities, but the form provides clear dates, share counts, and price. There is no indication of related-party transactions or deviations from Section 16 reporting requirements in the document provided.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Saba Capital Management, L.P.

(Last) (First) (Middle)

405 LEXINGTON AVENUE

58TH FLOOR

(Street)

NEW YORK NY 10174

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Gabelli Healthcare & WellnessRx Trust [ GRX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	X	10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
09/11/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	09/11/2025		P		6,147	A	$9.43	2,043,303	I	-
Common Stock	09/12/2025		P		7,732	A	$9.43	2,051,035	I	-

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

	Saba Capital Management, L.P. By: Zachary Gindes	09/15/2025
	Boaz Weinstein	09/15/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What transactions were reported on the GRX Form 4?

The filing reports two open-market purchases: 6,147 shares on 09/11/2025 and 7,732 shares on 09/12/2025, both at $9.43 per share.

How many GRX shares does Saba Capital indirectly own after these transactions?

Following the reported purchases, Saba Capital's indirect beneficial ownership is reported as 2,051,035 shares.

Who filed the Form 4 for GRX and how is the filer related to the issuer?

The Form 4 was filed by Saba Capital Management, L.P. and the reporting relationship is listed as Director and 10% owner.

When was the Form 4 for these GRX transactions signed?

The form is signed by Zachary Gindes and Boaz Weinstein on 09/15/2025.

Were any derivative securities reported in this Form 4 for GRX?

No derivative securities are reported; Table II in the filing contains no entries.